Lupin receives approval from the US FDA for its Selexipag for injection
In 2022, sales of the Selexipag Franchise in the US stood at $ 1.1 billion. The sales for January 1 to September 30, 2023, stood at $978 million
from Companies https://ift.tt/mdEoXpH
from Companies https://ift.tt/mdEoXpH
No comments: